Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dessel, Els van
LORD, NCT02492607: Management of Low-risk (Grade I and II) DCIS	Recruiting	N/A	2500	Europe	Standard treatment, digital mammography, Active surveillance, radiotherapy	The Netherlands Cancer Institute, Borstkanker Onderzoek Groep, European Organisation for Research and Treatment of Cancer - EORTC	DCIS	02/34	02/34
Smits, Marijn
NVALT28, NCT04597671: Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC	Recruiting	3	170	Europe	Durvalumab, Imfinzi, low-dose PCI, Prophylactic Cranial Irradiation (PCI)	Association NVALT Studies	Carcinoma, Non-Small-Cell Lung	12/28	12/32
Klem, Taco
BREHAB, NCT06076616: Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot Study	Completed	N/A	40	Europe	Prehabilitation and rehabilitation	Franciscus Gasthuis	Breast Cancer, Lifestyle, Rehabilitation, Prehabilitation, Surgery	12/23	01/24
LORD, NCT02492607: Management of Low-risk (Grade I and II) DCIS	Recruiting	N/A	2500	Europe	Standard treatment, digital mammography, Active surveillance, radiotherapy	The Netherlands Cancer Institute, Borstkanker Onderzoek Groep, European Organisation for Research and Treatment of Cancer - EORTC	DCIS	02/34	02/34